Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels - Wikidata - awgldk - TriplyDB

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

http://www.wikidata.org/entity/Q28363489

about

Is it time to modify the reverse cholesterol transport model?Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo Contribution of Hfe expression in macrophages to the regulation of hepatic hepcidin levels and iron loading ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport.Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction.Adipocyte modulation of high-density lipoprotein cholesterol.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1.Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2 Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.ABCA1 and nascent HDL biogenesis The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients.Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function ABCA1 rs4149313 polymorphism and susceptibility to coronary heart disease: a meta-analysis.Molecular regulation of HDL metabolism and function: implications for novel therapies.Endothelial cell metabolism in normal and diseased vasculature.New insights into the mechanism of low high-density lipoprotein cholesterol in obesity Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein The effect of regular aerobic exercise on reverse cholesterol transport A1 and apo lipoprotein a-I gene expression in inactive women.Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study ABCA1 and atherosclerosis.Gene therapy for lipoprotein disorders.Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis.Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.Tachometer for reverse cholesterol transport?Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome.BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.Emerging roles of the intestine in control of cholesterol metabolism.Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography.ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse

P2860

Q28363458-4F24EF4F-8140-4855-8B50-2FA7CC898550 Q28508467-C5E58672-C414-45D5-BBDF-213CC16B6371 Q28512327-CE444CF3-2248-4B59-9A7A-6FE774E7E16F Q28569109-BAFB04E3-C14F-42D8-A50A-895A1790707C Q30491802-F39DCC98-0B4B-469A-96B7-2C5A59078952 Q33642949-85AE77D8-2468-43FB-AFE8-500B83B512DD Q33660599-212BDE9D-40CB-4186-8EDC-31862FF7F043 Q33736540-C19FB17B-AD39-4556-94E3-7141A05DBDFD Q33901965-78A35DD5-47C8-4943-BF5B-B88861FEB57E Q33969250-432DEB00-2EEE-4737-8E8A-BB2696DA7E85 Q34077609-45A06753-494B-4119-A66F-BBBCFA4BFF8D Q34155049-7ED26CFB-97DD-4FD6-8103-A2F0B79CA760 Q34188006-C679B50C-B7C1-4A15-A695-3A40882C9706 Q34377352-0C77CAD6-3B75-4859-9EB6-7636DE14D005 Q34407326-2566D2E5-028A-4941-AF6E-680133A98FBF Q34559884-F5F5451B-43D7-416E-94F0-51D77F25F504 Q34610302-3428497E-8CEF-4C6F-A4F0-3B8B50EBF8FF Q34827947-6798A639-A918-455C-9F71-E1FA53568333 Q34958342-45CBB73C-B6C3-41C1-A8E7-28AE28973979 Q35120954-36ACC463-6544-4647-899D-3E9546815567 Q35131581-8D2043BD-023F-48B6-956D-D95383EBF0DC Q35190580-2F67755A-8B2D-4984-ADA5-36679A43AB80 Q35191066-98FF38B4-5E2F-4E42-BAED-EA5002BED80E Q35234625-85CF9CE4-4910-4369-8B0F-61D295E1D32A Q35521069-7DD3C17A-2599-4D5B-87A8-0E68303A8E97 Q35536400-67F92BD3-3165-484A-8153-8CD5F3C2CCEF Q35644550-41BF73C5-13FB-429C-85BC-A98AB3C03A26 Q36037988-248FA139-A493-414F-9F07-E2069E4507F6 Q36110734-56FF2EEF-9CC4-4055-82EB-FDEC233640BA Q36192289-A82D7890-B6D8-4A6E-90EF-B0C9863DF23D Q36210853-2E2C0588-296C-4169-8B54-C40DA1117213 Q36304339-7B4BDD51-880F-458F-8359-E4DE775C7CD3 Q36306579-A1D5AE7C-6184-4250-A724-63247D9925FB Q36366228-98346511-891E-49C7-A310-B3A4CB65E93B Q36408997-0FBE0155-403F-420E-B2B0-16999A542B78 Q36626246-B186F1F5-72CD-4BC7-AAA4-0E3C3CD6AA93 Q36638194-6FE6F2DE-14B2-427B-9AFF-EF01411DF3DD Q36945097-78EA97D0-2196-4A55-BB69-F8C10DBCFF86 Q37172481-6D7CE24F-60F4-4550-94FD-0ABC70EDDA04 Q37222407-223B9561-5ACB-46B9-9AB9-0EEF5270DB1D

P2860

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

http://www.wikidata.org/entity/Q28363489

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@ast

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@en

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@nl

type

label

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@ast

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@en

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@nl

prefLabel

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@ast

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@en

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@nl

P1433

Q28363489-518F6FF2-D03A-4346-A2E8-64A0A0124895

P1476

Q28363489-F48F3D74-39B3-4B0B-8B24-ABB88950BCE4

P2093

Q28363489-1865C02A-9476-4D4C-94B3-230F65A8FE63

Q28363489-41FC0961-7093-4FCC-9E64-0C2D1F7A4FE7

Q28363489-5F9C2B7C-B8DF-414B-9345-460E9D489860

Q28363489-DA9E8D86-C674-4EBA-BAAD-A565EF347A4F

P2860

Q28363489-013ED498-3925-450F-BE5E-4AC8CE6EA88F

Q28363489-0450F1D5-5610-4086-A608-9BAAA7263041

Q28363489-2608B862-3E27-4779-AA9D-C53608515B90

Q28363489-361B8C59-D76D-4C2F-B759-DF088C43BFEB

Q28363489-3C5330E5-51D0-488B-921C-B66CE9A80373

Q28363489-5E848011-8103-4339-8F78-40CA8DBE85E2

Q28363489-838C9358-7812-48A3-A3E6-06A27A2E96ED

Q28363489-849EB3FA-CFAC-4E73-BB8B-456A4A4C0BA4

Q28363489-89F8CE9A-E9FD-40A9-BF49-96724ADA1E21

Q28363489-8F66D3DA-C744-47AD-8A38-4F923DBC83C3

P304

Q28363489-00D29BFB-5DC0-4F16-A3E9-DC63B730B59B

P31

Q28363489-AE671CD0-D9C2-4C6E-8C99-F2AA3A73F4E6

P3181

Q28363489-4841C842-9D3C-453C-9D51-1C26FD20362F

P356

Q28363489-16640D7A-5626-4537-85F5-7C63777C983D

Q28363489-266D2FCC-828F-4861-9D90-E32B60E76A9E

P407

Q28363489-3FF2DF7E-5198-4255-8B22-CB8F2C550081

P433

Q28363489-583B7AE6-5152-4450-84A1-17ADA0691590

P478

Q28363489-A3907F1D-7A99-4589-8F93-100BC01B5F9E

P577

Q28363489-97CB5455-1E23-45B6-8472-F2A6D106398E

P698

Q28363489-EFABB8C0-4BAD-41B8-842D-973F5FB4B0B0

P921

Q28363489-8E8D0AFA-ACF3-466A-BB52-54EBAEE7BF13

P932

Q28363489-D74B83D0-8A7F-48F0-9B94-CDF1B5A1E753

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

@en

P2093

M Haghpassand

http://www.w3.org/2001/XMLSchema#string

O L Francone

http://www.w3.org/2001/XMLSchema#string

P A Bourassa

http://www.w3.org/2001/XMLSchema#string

R J Aiello

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

The pathogenesis of atherosclerosis: a perspective for the 1990s

Cell cholesterol efflux: integration of old and new observations provides new insights.

Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.

Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver

P304

1315-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3938075

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI12810

http://www.w3.org/2001/XMLSchema#string

10.1172/JCI200112810

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11696576

http://www.w3.org/2001/XMLSchema#string

P921

P932

209438

http://www.w3.org/2001/XMLSchema#string